协商一致会议
医学
幽门螺杆菌
幽门螺杆菌感染
重症监护医学
阿司匹林
疾病
内科学
临床实习
胃肠病学
家庭医学
作者
Peter Malfertheiner,Françis Mégraud,Colm OʼMorain,J. Atherton,Anthony Axon,Franco Bazzoli,Gian Franco Gensini,Javier P. Gisbert,David Y. Graham,Theodore Rokkas,Emad El‐Omar,Ernst J. Kuipers
出处
期刊:Gut
[BMJ]
日期:2012-04-05
卷期号:61 (5): 646-664
被引量:2200
标识
DOI:10.1136/gutjnl-2012-302084
摘要
Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.
科研通智能强力驱动
Strongly Powered by AbleSci AI